Narrow search
Showing 1 - 10 of 1,437
Cover Image
Prevention of Recurrent Rhinopharyngitis in At-Risk Children in France: A Cost-Effectiveness Model for a Nonspecific Immunostimulating Bacterial Extract (OM-85 BV)
Pessey, Jean-Jacques; Megas, Francoise; Arnould, Benoit; … - In: PharmacoEconomics 21 (2003) 14, pp. 1053-1068
rhinopharyngitis (RARP) in at-risk children with OM-85 BV, an immunostimulating agent indicated for the prevention of recurrences …
Persistent link: https://www.econbiz.de/10005243125
Cover Image
A Willingness-To-Pay Assessment of Parents' Preference for Shorter Duration Treatment of Acute Otitis Media in Children
Gueylard Chenevier, Delphine; LeLorier, Jacques - In: PharmacoEconomics 23 (2005) 12, pp. 1243-1255
conventional antibacterial therapy for acute otitis media (AOM). Methods: The study population consisted of 562 parents of children … multivariate analysis to estimate possible predictors of parental WTP. Results: The children with AOM were representative of the … experiencing adverse effects of treatment. Conclusion: Parents of children with AOM were willing to pay more for their child to …
Persistent link: https://www.econbiz.de/10005243164
Cover Image
Varicella Vaccination in Italy: An Economic Evaluation of Different Scenarios
Coudeville, Laurent; Brunot, Alain; Giaquinto, Carlo; … - In: PharmacoEconomics 22 (2004) 13, pp. 839-855
Aim: To determine the economic impact (cost-benefit analysis) of childhood varicella vaccination, with the Oka/Merck varicella zoster virus vaccine live (Varivax(R)) in Italy. Methods: This analysis is based on an epidemiological model of varicella zoster virus (VZV) dynamics adapted to the...
Persistent link: https://www.econbiz.de/10005243180
Cover Image
Anti-Inflammatory Medication Adherence, Healthcare Utilization and Expenditures among Medicaid and Children's Health Insurance Program Enrollees with Asthma
Herndon, Jill Boylston.; Mattke, Soeren; Evans Cuellar, … - In: PharmacoEconomics 30 (2012) 5, pp. 397-412
Background:Background: Underuse of controller therapy among Medicaid-enrolled children is common and leads to more …) and leukotriene inhibitors (LI), and healthcare utilization and expenditures among children enrolled in Medicaid and the … Children's Health Insurance Program in Florida and Texas in the US. Abstract: Methods:Methods: The sample for this …
Persistent link: https://www.econbiz.de/10010541097
Cover Image
Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity D...
Sikirica, Vanja; Haim Erder, M.; Xie, Jipan; Macaulay, Dendy - In: PharmacoEconomics 30 (2012) 8, pp. 1-1
, affecting 3-7% of school-age children in the US and imposing substantial economic burden. Stimulants are considered first …-line pharmacological treatment and are the most prescribed treatment for ADHD. However, approximately 30% of children with ADHD do not have … stimulants versus maintaining existing stimulant monotherapy in the treatment of ADHD in children and adolescents with suboptimal …
Persistent link: https://www.econbiz.de/10010556689
Cover Image
Valuation of the Child Health Utility 9D Index
Stevens, Katherine - In: PharmacoEconomics 30 (2012) 8, pp. 729-747
-related quality of life for children aged 7-11 years. The estimation of preference weights will allow the calculation of QALYs for use … the impact of children's preferences for the health states and what methods could be used to obtain these preferences. …
Persistent link: https://www.econbiz.de/10010556690
Cover Image
Preference-Based Health-Related Quality-of-Life Outcomes in Children with Autism Spectrum Disorders: A Comparison of Generic Instruments
Tilford, J. Mick.; Payakachat, Nalin; Kovacs, Erica; … - In: PharmacoEconomics 30 (2012) 8, pp. 661-679
Background:Background: Cost-effectiveness analysis of pharmaceutical and other treatments for children with autism … private payers, but methods for measuring QALYs in children are under-studied. No cost-effectiveness analyses have been …-related quality-of-life (HR-QOL) outcomes in children with ASDs and compares the sensitivity of two generic preference …
Persistent link: https://www.econbiz.de/10010556691
Cover Image
Valuing Children's Health: Whose Quality of Life Matters?
Wittenberg, Eve - In: PharmacoEconomics 30 (2012) 8, pp. 633-635
Persistent link: https://www.econbiz.de/10010556693
Cover Image
A Parent-Child Dyad Approach to the Assessment of Health Status and Health-Related Quality of Life in Children with Asthma
Ungar, Wendy J.; Boydell, Katherine; Dell, Sharon; … - In: PharmacoEconomics 30 (2012) 8, pp. 697-712
's age and cognitive ability. Parent-proxy reports are known to differ from children's reports. Simultaneous assessment using … Pediatric Asthma Quality of Life Questionnaire (PAQLQ). Questionnaires were administered by interview to children and parents … assess convergent validity. Test-retest reliability was assessed in 28 children who remained clinically stable between visits …
Persistent link: https://www.econbiz.de/10010556694
Cover Image
Comparative Effectiveness and Child Health
Prosser, Lisa A. - In: PharmacoEconomics 30 (2012) 8, pp. 637-645
to aspects of health and healthcare that are specific to children. These special considerations include the role of … children represents an exciting opportunity to provide evidence that can guide clinical and policy decisions for child health. …
Persistent link: https://www.econbiz.de/10010556695